Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nick

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Cancer Biology & Therapy|September 10, 2009
Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaWilliam M Merritt, Christopher G Danes, Mian M K Shahzad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Functional roles of Src and Fgr in ovarian carcinomaHye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Journal of the National Cancer Institute|July 31, 2009
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaJeong-Won Lee, Hee Dong Han, Mian M K Shahzad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinomaJeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Biology & Therapy|October 16, 2010
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M Merritt, Aparna A Kamat, Jee-Young Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
American Journal of Obstetrics and Gynecology|August 18, 2020
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancerShannon N Westin, Bryan Fellman, Charlotte C Sun, et al.
Journal of the National Cancer Institute|September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell deathAlpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Cancer Biology & Therapy|September 10, 2009
Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaWilliam M Merritt, Christopher G Danes, Mian M K Shahzad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Functional roles of Src and Fgr in ovarian carcinomaHye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Journal of the National Cancer Institute|July 31, 2009
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaJeong-Won Lee, Hee Dong Han, Mian M K Shahzad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinomaJeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Biology & Therapy|October 16, 2010
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M Merritt, Aparna A Kamat, Jee-Young Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
American Journal of Obstetrics and Gynecology|August 18, 2020
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancerShannon N Westin, Bryan Fellman, Charlotte C Sun, et al.
Journal of the National Cancer Institute|September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell deathAlpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Pageof 16